Home › Funds › Douglas Lane & Associates, LLC › JNJ

Douglas Lane & Associates, LLC position in JNJ

JOHNSON & JOHNSON · Health Care

Douglas Lane & Associates, LLC reported holding 643,935 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$170.5M, representing 2.28% of its reported portfolio and ranking #6 among its reported holdings. Douglas Lane & Associates, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)643.93K sh
Reported value held$170.48M
Portfolio Weight2.28%
First reportedQ3 2023
Last changeReduce
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How Douglas Lane & Associates, LLC's JNJ position evolved

Douglas Lane & Associates, LLC first disclosed a stake in JNJ in Q3 2023 at 480,205 shares (US$74.8M). The position peaked in Q3 2026 at 643,935 shares, worth US$170.5M. Across 13 filings, Douglas Lane & Associates, LLC increased the stake 9 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 643,935 shares valued at US$170.5M — a reduction of -19,732 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 480.20K $74.79M New
Q4 2023 520.57K $81.59M Add
Q1 2024 545.25K $86.25M Add
Q2 2024 577.35K $84.39M Add
Q3 2024 592.86K $96.08M Add
Q4 2024 599.39K $86.68M Add
Q1 2025 617.67K $102.44M Add
Q2 2025 632.42K $96.60M Add
Q3 2025 667.37K $123.74M Add
Q4 2025 680.23K $140.77M Add
Q1 2026 672.70K $164.44M Reduce
Q2 2026 663.67K $168.55M Reduce
Q3 2026 643.93K $170.48M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Douglas Lane & Associates, LLC held JNJ?

Douglas Lane & Associates, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Douglas Lane & Associates, LLC's current position in JNJ?

As of Q3 2026, Douglas Lane & Associates, LLC holds 643.93K shares of JNJ (JOHNSON & JOHNSON), valued at $170.48M, representing 2.28% of its reported portfolio and ranking #6.

Has Douglas Lane & Associates, LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Douglas Lane & Associates, LLC reduced its position in JNJ. The position peaked in Q3 2026 at 643.93K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.